Agribusiness

 

Consumer Goods

 

Heavy Industry

 

Hi-Tech & Media

 

Life Sciences

 

Services

Talk to Alison

00 1 718 618 48 97

Add to circles RSS feed

Search inside this page

Top countries

Publication dates

Publishers

data types

Free Market Research Guides to Download

Free Market Research Guides to Download

Conduct your own Porter Five Forces Analysis on the Biological Therapy Industry

Assess your competitors in the Biological Therapy Industry

Conduct your own Pestel Analysis

Biological Therapy Analysis & Statistics, September 2011 (p9)

You might be interested in: stem cell, cell therapy, cytokine, more »

» Purchase Premium Reports

241-270 of about 300 reports
Cytokine PharmaSciences, Inc. (formerly Cytokine Networks, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cytokine PharmaSciences, Inc. (formerly Cytokine Networks, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2011
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
International Brachytherapy s.a. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

International Brachytherapy s.a. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2011
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
Competitor Analysis: Her2 and Her3 Receptor Antagonists

Competitor Analysis: Her2 and Her3 Receptor Antagonists

  • $ 387
  • Industry report
  • September 2011
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Her2 and Her3 receptor antagonists provides a competitor evaluation in the field of Her2 (ErbB2) and Her3 receptor targeting molecules ...

  • Industries : Biological Therapy
Stem Cell Innovations Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Stem Cell Innovations Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2011
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
World Biological Therapy: Plasma Cell Neoplasm - Pipeline Review, H2 2011

World Biological Therapy: Plasma Cell Neoplasm - Pipeline Review, H2 2011

  • $ 500
  • Industry report
  • August 2011
  • by Global Markets Direct

This report provides information on the therapeutic development for Plasma Cell Neoplasm, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

  • Industries : Biological Therapy
  • Countries : World
Biological Therapy Industry: Indolent Lymphoma - Pipeline Review, H2 2011

Biological Therapy Industry: Indolent Lymphoma - Pipeline Review, H2 2011

  • $ 500
  • Industry report
  • August 2011
  • by Global Markets Direct

This report provides information on the therapeutic development for Indolent Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Biological Therapy
  • Countries : World
World Biological Therapy: Primary Systemic Amyloidosis - Pipeline Review, H2 2011

World Biological Therapy: Primary Systemic Amyloidosis - Pipeline Review, H2 2011

  • $ 500
  • Industry report
  • August 2011
  • by Global Markets Direct

This report provides information on the therapeutic development for Primary Systemic Amyloidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

  • Industries : Biological Therapy
  • Countries : World
Pathology Industry: T-Cell Lymphomas - Pipeline Review, H2 2011

Pathology Industry: T-Cell Lymphomas - Pipeline Review, H2 2011

  • $ 500
  • Industry report
  • August 2011
  • by Global Markets Direct

This report provides information on the therapeutic development for T-Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Biological Therapy
  • Countries : United States
World Biological Therapy: Oligodendroglioma - Pipeline Review, H2 2011

World Biological Therapy: Oligodendroglioma - Pipeline Review, H2 2011

  • $ 500
  • Industry report
  • August 2011
  • by Global Markets Direct

This report provides information on the therapeutic development for Oligodendroglioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Biological Therapy
  • Countries : World
Takara Holdings Inc. (Symbol:TYO) SWOT Analysis, Strategy, Revenues and Profits

Takara Holdings Inc. (Symbol:TYO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • August 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
World Biological Therapy: Natural Killer Cell Lymphomas - Pipeline Review, Q3 2011

World Biological Therapy: Natural Killer Cell Lymphomas - Pipeline Review, Q3 2011

  • $ 500
  • Company report
  • July 2011
  • by Global Markets Direct

This report provides data on the therapeutic development for Natural Killer Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

  • Industries : Biological Therapy
  • Countries : World
Biological Therapy Industry: T-Cell Leukemia - Pipeline Review, Q3 2011

Biological Therapy Industry: T-Cell Leukemia - Pipeline Review, Q3 2011

  • $ 500
  • Company report
  • July 2011
  • by Global Markets Direct

This report provides data on the therapeutic development for T-cell Leukemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Biological Therapy
  • Countries : World
iPS cell Generation

iPS cell Generation" Patent Landscape 2011

  • $ 4 200
  • Industry report
  • July 2011
  • by France Innovation Scientifique et Transfert

IP Overview presents a patent mapping analysis of the ?induced pluripotent stem cell? field. Stem cell based therapies raise high hope concerning the treatment of several human diseases. However, there ...

  • Industries : Biological Therapy
Biological Therapy Industry: Behcet%s Disease - Pipeline Review, Q2 2011

Biological Therapy Industry: Behcet%s Disease - Pipeline Review, Q2 2011

  • $ 500
  • Industry report
  • June 2011
  • by Global Markets Direct

Behcet's Disease - Pipeline Review, Q2 2011 What's inside this report? Global Industry s Direct's, 'Behcet's Disease - Pipeline Review, Q2 2011', provides an overview of the Behcet's Disease therapeutic ...

  • Industries : Biological Therapy
  • Countries : United States, World
Biological Therapy Industry: Alpha-Mannosidosis - Pipeline Review, Q2 2011

Biological Therapy Industry: Alpha-Mannosidosis - Pipeline Review, Q2 2011

  • $ 500
  • Industry report
  • June 2011
  • by Global Markets Direct

This report provides information on the therapeutic development for Alpha-Mannosidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

  • Industries : Biological Therapy
  • Countries : World
The Stem Cell Market Outlook

The Stem Cell Market Outlook

  • $ 3 835
  • Industry report
  • June 2011
  • by SCRIP Insights

Introduction This report covers the commercialization of stem cells (primarily derived from adult tissues) which are transplanted into patients to improve the function of diseased/damaged tissues/organs. ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Spain, Italy, France, Germany, India, China
StemCells, Inc. (Symbol:STEM) SWOT Analysis, Strategy, Revenues and Profits

StemCells, Inc. (Symbol:STEM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • May 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Alliqua, Inc. (Symbol:HPLF) SWOT Analysis, Strategy, Revenues and Profits

Alliqua, Inc. (Symbol:HPLF) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • May 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Mesoblast Ltd (Symbol:MSB) SWOT Analysis, Strategy, Revenues and Profits

Mesoblast Ltd (Symbol:MSB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Australia
Biological Therapy Industry: Sjogren%s Syndrome - Pipeline Review, Q2 2011

Biological Therapy Industry: Sjogren%s Syndrome - Pipeline Review, Q2 2011

  • $ 500
  • Company report
  • May 2011
  • by Global Markets Direct

Sjogren's Syndrome - Pipeline Review, Q2 2011 Global Industry s Direct's, 'Sjogren's Syndrome - Pipeline Review, Q2 2011', provides an overview of the Sjogren's Syndrome therapeutic pipeline. This report ...

  • Industries : Biological Therapy
  • Countries : World
BioTime, Inc. (Symbol:BTIM) SWOT Analysis, Strategy, Revenues and Profits

BioTime, Inc. (Symbol:BTIM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Cord Blood, Embryonic and Adult Stem Cells Applications & Technologies - A Global Market Watch, 2009-2015

Cord Blood, Embryonic and Adult Stem Cells Applications & Technologies - A Global Market Watch, 2009-2015

  • $ 4 710
  • Industry report
  • May 2011
  • by Axis Research Mind

REPORT DESCRIPTION GLOBAL MARKET WATCH Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during ...

  • Industries : Biological Therapy
  • Countries : World
Cryopreservation Equipments in Stem Cells - A Global Market Watch, 2009-2015

Cryopreservation Equipments in Stem Cells - A Global Market Watch, 2009-2015

  • $ 3 540
  • Industry report
  • May 2011
  • by Axis Research Mind

REPORT DESCRIPTION Global Market Watch With a CAGR of 23.7%, global market value for cryopreservation equipments used in stem cells industry is anticipated to worth US$2.2 billion by 2015. On a global ...

  • Industries : Biological Therapy
  • Countries : World
Biological Therapy Industry: Lysosomal Storage Disorder - Pipeline Review, Q2 2011

Biological Therapy Industry: Lysosomal Storage Disorder - Pipeline Review, Q2 2011

  • $ 500
  • Company report
  • April 2011
  • by Global Markets Direct

This report provides data on the therapeutic development for Lysosomal Storage Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

  • Industries : Biological Therapy
  • Countries : World
Biological Therapy Industry: Plasma Cell Neoplasm - Pipeline Review, Q2 2011

Biological Therapy Industry: Plasma Cell Neoplasm - Pipeline Review, Q2 2011

  • $ 500
  • Company report
  • April 2011
  • by Global Markets Direct

This report provides data on the therapeutic development for Plasma Cell Neoplasm, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Biological Therapy
  • Countries : World
Biological Therapy Industry: Indolent Lymphoma - Pipeline Review, Q2 2011

Biological Therapy Industry: Indolent Lymphoma - Pipeline Review, Q2 2011

  • $ 500
  • Company report
  • April 2011
  • by Global Markets Direct

This report provides data on the therapeutic development for Indolent Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Biological Therapy
  • Countries : United States
Biological Therapy Industry: Primary Systemic Amyloidosis - Pipeline Review, Q2 2011

Biological Therapy Industry: Primary Systemic Amyloidosis - Pipeline Review, Q2 2011

  • $ 500
  • Industry report
  • April 2011
  • by Global Markets Direct

This report provides information on the therapeutic development for Primary Systemic Amyloidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

  • Industries : Biological Therapy
  • Countries : World
US Stem Cell Market Analysis

US Stem Cell Market Analysis

  • $ 800
  • Industry report
  • April 2011
  • by RNCOS

The stem cell market has been growing at a fast pace for the past few years and despite recession, the US continued to witness positive developments and massive investments in this industry. Using stem ...

  • Industries : Biological Therapy
  • Countries : United States
Biopharmaceutical Industry: Acromegaly And Gigantism (Growth Hormone Disorders) - Pipeline Review, Q1 2011

Biopharmaceutical Industry: Acromegaly And Gigantism (Growth Hormone Disorders) - Pipeline Review, Q1 2011

  • $ 500
  • Company report
  • March 2011
  • by Global Markets Direct

This report provides data on the therapeutic development for Acromegaly And Gigantism (Growth Hormone Disorders), complete with latest updates, and special features on late-stage and discontinued projects. ...

  • Industries : Biological Therapy
  • Countries : Israel, World
Biological Therapy Industry: PETHEMA - Developmental Therapeutics Review - Q1 2011

Biological Therapy Industry: PETHEMA - Developmental Therapeutics Review - Q1 2011

  • $ 500
  • Company report
  • March 2011
  • by Global Markets Direct

The report includes data on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable). This report is built using data and information sourced ...

  • Industries : Biological Therapy
  • Countries : World

» Download Public Reports

About 1 100 reports
Company Report: Biological Therapy in The United States and France for Year 2013

Company Report: Biological Therapy in The United States and France for Year 2013

  • Company report
  • April 2013
  • 3 pages
  • by Governmental Agency

Company Report: Biological Therapy In China For Year 2013

March 2013

Company Report: Stem Cell In The United States For Year 2013

March 2013

Company Report: Cell Therapy For Year 2013

April 2013

Company Report: Biological Therapy In The United States For Year ...

April 2013

Company Report: Stem Cell In The United States And Israel For Yea ...

May 2013

Company Report: Biological Therapy For Year 2013

April 2013

Company Report: Biological Therapy In The United States For Year ...

June 2013

The Israeli Stem Cell Market : Innovation And Technology Trends ( ...

May 2013

The Japanese Biological Therapy Business : Innovation And Technol ...

April 2013
More Reports to Download »

» Read our Company Profiles

38 Companies

GlaxoSmithKline P.L.C.

United States

Bioheart Inc.

United States

Celgene Corp.

United States

StemCells Inc.

United States

Geron Corp.

United States
More Companies »

Privacy Policy by TRUSTe

Reportlinker.com © Copyright 2013. All rights reserved.

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.